Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)
Recruiting · NCT06481163 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Buruli ulcer disease, Infections, Mycobacterium Infections, Nontuberculous, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, skin disorder, ulcer disease | Recruiting | Phase 2 | 2026-06-30 | NCT06481163 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Barwon Health | 4 |
| Global Alliance for TB Drug Development | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barwon Health | Geelong | Australia | 17 |
| Royal Melbourne Hospital | Melbourne | Australia | 5 |